Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:4.1.2.13 (
aldolase
)
3,461
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Acute arterial obstruction in hind limb was experimentally induced by intra-arterial injection of sodium laurate saline solution in mongrel dogs, and the inhibitory action of cilostazol (6-[4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy]- 3,4-dihydro-2(1H)-quinolinone, OPC-13013) on ulcer formation was studied.
Cilostazol
at oral doses of 10 and 30 mg/kg inhibited ulcer development.
Cilostazol
inhibited decrease in skin temperature in obstructed hindlimbs in a dose-dependent manner.
Cilostazol
also inhibited increase of plasma
aldolase
, creatine phosphokinase and glutamic oxalacetic transaminase activities, presumably due to necrosis of the skeletal muscle.
...
PMID:Effect of cilostazol, a new antithrombotic drug, on an experimental model of peripheral circulation insufficiency. 407 28